Docteur Coline DARON
✨ Profil synthétique
IA · 30/04/2026Le Docteur Coline DARON est un rhumatologue hospitalier à Vichy, avec des intérêts de recherche dans les domaines de la spondyloarthrite, de la santé osseuse et des maladies rhumatismales. Ses publications sur PubMed couvrent des essais cliniques, la pharmacovigilance et des revues/méta-analyses. Avec un h-index de 3 et 5 publications, il contribue à la communauté scientifique dans son domaine.
Expertises présumées
- Spondyloarthritis
- Rheumatoid Arthritis
- Santé osseuse
- Celiac Disease
- Microscopic Colitis
- Essais cliniques
- Pharmacovigilance
Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.
Diplômes
🎓 DES & spécialité ordinale
- DES Rhumatologie
- Rhumatologie (SM)
🎓 Diplômes
- DE Docteur en médecine
Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.
Activité de recherche & publications
Source : bases de données publiques (OpenAlex, PubMed).
h-index
3
h articles cités ≥ h fois chacun. Un h de 3 = 3 publications avec 3+ citations.
Citations
31
Publications
5
i10-index
1
Thématiques principales
- Spondyloarthritis Studies and Treatments ×2
- Bone health and treatments ×2
- Celiac Disease Research and Management ×2
- Microscopic Colitis ×2
- Rheumatoid Arthritis Research and Therapies ×1
Affiliations FR : Centre Hospitalier Universitaire de Clermont-Ferrand
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Bibliographie
Viewpoints of dentists on the use of bisphosphonates in rheumatology patients
2018ArticleInternational Dental Journal
Efficacy and safety of pamidronate in Modic type 1 changes: study protocol for a prospective randomized controlled clinical trial.
2014ArticleTrials
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Livres & ouvrages
Source : Google Books — filtre catégories médicales/santé/sciences.
Lieu de consultation
CH JACQUES LACARIN VICHY
Boulevard DENIERE, 03201 Vichy
Tarifs & secteur de conventionnement
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Prendre rendez-vous & contact
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Top publications · les plus citées
- 2Psoriatic arthritis treated by anti-TNFs: a monocentric trial of 102 cases in Auvergne, France
Clinical and experimental rheumatology · 2016
📚 5 citations - 3Efficacy and safety of pamidronate in Modic type 1 changes: study protocol for a prospective randomized controlled clinical trial
Trials · 2014
Lire l'abstract Crossref ↓
Abstract Background Erosive degenerative disc disease, also known as Modic type 1 changes, is usually characterized by low back pain with an inflammatory pain pattern, as seen in spondyloarthropathies. Intravenous pamidronate has proven to be effective in patients with ankylosing spondylitis who are refractory to nonsteroidal antiinflammatory drugs, and in painful bone diseases in general, such as Paget’s disease, fibrous dysplasia or vertebral fractures. We therefore hypothesize that pamidronate would be effective in treating low back pain associated with Modic type 1 changes. Methods/Design This study, called PEPTIDE (short for the French title “Etude Prospective sur l’Efficacité et la tolérance du PamidronaTe dans les dIscopathies Degeneratives Erosives”), will be a double-blind, randomized, placebo-controlled, parallel group, phase two clinical trial. A total of 48 patients will be recruited. These patients will be randomly assigned to one of the two groups, with 24 patients in each group: one group will be given pamidronate and the other a placebo. Pamidronate will be administered at a dose of 90 mg per day for two days consecutively, and every patient, irrespective of treatment group, will be given paracetamol to maintain blinding by preventing drug-induced fever. The primary outcome measure is a between-group difference of 30 points on a 100 mm Visual Analogue Scale (VAS) at three months. Secondary outcome measures are improvement in functional status and the drug’s safety. Primary and secondary outcome measures will be assessed at each visit (inclusion, at six weeks, three months, and six months). If the primary goal is not attained, the patient will be offered a rigid or semi-rigid back brace, irrespective of the treatment group. Discussion To date, only local treatments, for example intradiscal corticosteroid therapy, lumbar arthrodesis or back braces have been studied in randomized, controlled trials, with controversial results. This trial is currently ongoing and, if conclusive, should provide physicians with an acceptable alternative to those treatments. The results should be publicly available in spring 2015. Trial registration ClinicalTrials.gov number, NCT01799616.
Publications scientifiques (4) — classées par pathologie
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Transversal2
▼
Transversal2
▼- Viewpoints of dentists on the use of bisphosphonates in rheumatology patients
International dental journal · 2018 · Journal Article
Daron C, Deschaumes C, Soubrier M, Mathieu S
- Psoriatic arthritis treated by anti-TNFs: a monocentric trial of 102 cases in Auvergne, France
Clinical and experimental rheumatology · 2016 · Journal Article
Soubrier M, Pereira B, Frayssac T, Abdi D, et al.
📚 5 cit.🔬→🩺 Translationnel
Essai clinique1
▼
Essai clinique1
▼- Efficacy and safety of pamidronate in Modic type 1 changes: study protocol for a prospective randomized controlled clinical trial
Trials · 2014 · Clinical Trial, Phase II
Cecchetti S, Pereira B, Roche A, Deschaumes C, et al.
📚 5 cit.🩺 Clinique
Pharmacovigilance1
▼
Pharmacovigilance1
▼- Efficacy and safety of pamidronate in Modic type 1 changes: study protocol for a prospective randomized controlled clinical trial
Trials · 2014 · Clinical Trial, Phase II
Cecchetti S, Pereira B, Roche A, Deschaumes C, et al.
📚 5 cit.🩺 Clinique
Revue / méta-analyse1
▼
Revue / méta-analyse1
▼- Occurrence of rheumatic symptoms in celiac disease: A meta-analysis: Comment on the article "Osteoarticular manifestations of celiac disease and non-celiac gluten hypersensitivity" by Dos Santos and Lioté. Joint Bone Spine 2016, doi:10.1016/j.jbspin.2016.09.007
Joint bone spine · 2017 · Letter
Daron C, Soubrier M, Mathieu S
📚 14 cit.
